Prevalence and severity of pterygium in Somalian male population: Can Khat consumption have a synergistic effect with ultraviolet radiation?

Aim: To investigate the relationship between khat consumption, UV radiation and pterygium among male population in Somalia.Materials and Methods: Between November 2019 and February 2020, 2,200 patients were examined. 146 patients who met the criteria among 335 patients with primary pterygium were included in the study. Ocular examinations were performed using slit-lamp biomicroscope. Patients were evaluated in terms of outdoor work, age, medical treatment history of pterygium, use of glasses or hats, family history, location of pterygium and eye with pterygium.Results: In this study, 146 patients with pterygium were examined. The cases were divided into two groups as grade 3 (42 patients, 28.8%) and non-grade 3 (104, 71.2%). The mean age of the patients was 43.5 ± 9.7 years. When the demographic findings of grade 3 and non-grade 3 patients were compared, khat use (p

PDF

___

1. Bradley JC, Yang W, Bradley RH, et al. The science of pterygia. Br J Ophthalmol 2010;94:815–20.
2. Errais K, Bouden J, Mili-Boussen I, et al. Effect of pterygium surgery on corneal topography. Eur J Ophthalmol 2008;18:177–81.
3. Malozhen SA, Trufanov SV, Krakhmaleva DA. Pterygium: etiology, pathogenesis, treatment. Vestn Oftalmol 2017;133: 76-83.
4. Rong SS, Peng Y, Liang YB, et al. Does cigarette smoking alter the risk of pterygium? a systematic review and meta-analysis. Investig Opthalmology Vis Sci 2014;55:6235.
5. Asokan R, Venkatasubbu RS, Velumuri L, et al. Prevalence and associated factors for pterygium and pinguecula in a South Indian population. Ophthalmic Physiol Opt 2012;32:39–44.
6. Sallam MA, Sheikh KA, Baxendale R, et al. The physiological and ergogenic effects of khat ( Catha edulis Forsk) Extract. Subst Use Misuse 2018;53:94– 100.
7. Atlabachew M, Combrinck S, Viljoen AM, et al. Isolation and in vitro permeation of phenylpropylamino alkaloids from Khat (Catha edulis) across oral and intestinal mucosal tissues. J Ethnopharmacol 2016;194:307– 15.
8. Geresu B. Khat (Catha edulis F.) and cannabinoids: Parallel and contrasting behavioral effects in preclinical and clinical studies. Pharmacol Biochem Behav 2015;138:164–73.
9. Yu S, Zhu L, Shen Q, et al. Recent Advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology. Behav Neurol 2015;2015:1–11.
10. Ljubojevic V, Gajanin R, Amidzic L, et al. The expression and significance of p53 protein and Ki-67 protein in pterygium. Vojnosanit Pregl 2016;73:16–20.
11. West S, Munoz B. Prevalence of pterygium in Latinos: Proyecto VER. Br J Ophthalmol 2009;93:1287–90.
12. Anbesse DH, Kassa T, Kefyalew B, et al. Prevalence and associated factors of pterygium among adults living in Gondar city, Northwest Ethiopia. PLoS One 2017;12:e0174450.
13. Achigbu E, Ezepue U. Prevalence and severity of pterygium among commercial motorcycle riders in south eastern Nigeria. Ghana Med J 2014;48:153.
14. Simmons SJ, Leyrer-Jackson JM, Oliver CF, et al. DARK Classics in Chemical Neuroscience: Cathinone- Derived Psychostimulants. ACS Chem Neurosci 2018;9:2379–94.
15. 15. Lu T, Kim PP, Greig NH, et al. Dopaminergic Neuron-Specific Deletion of p53 Gene Attenuates Methamphetamine Neurotoxicity. Neurotox Res 2017; 32:218–30.
16. Kim A, Mandyam CD. Methamphetamine affects cell proliferation in the medial prefrontal cortex: A new niche for toxicity. Pharmacol Biochem Behav 2014;126:90–6.
17. Liu L, Wu J, Geng J, et al. Geographical prevalence and risk factors for pterygium: a systematic review and meta-analysis. BMJ Open 2013;3:e003787.
18. Shiroma H, Higa A, Sawaguchi S, et al. Prevalence and Risk Factors of Pterygium in a Southwestern Island of Japan: The Kumejima Study. Am J Ophthalmol 2009;148:766-71.e1.
19. Reisman D, McFadden JW, Lu G. Loss of heterozygosity and p53 expression in Pterygium. Cancer Lett 2004;206:77–83.
20. Onur C, Orhan D, Orhan M, et al. Expression of p53 protein in pterygium. Eur J Ophthalmol 1998;8:157– 61.
21. Lu J, Wang Z, Lu P, et al. Pterygium in an aged Mongolian population: a population-based study in China. Eye 2009;23:421–7.
22. Tan CSH, Lim TH, Koh WP, et al. Epidemiology of pterygium on a tropical island in the Riau Archipelago. Eye 2006;20:908–12.
23. Verlee DL. Ophthalmic survey in the solomon islands. Am J Ophthalmol 1968;66:304–19.
24. Jha KN. High Altitude and the eye. Asia-Pacific J Ophthalmol 2012;1:166–9.
25. Maharjan I, Shreshth E, Gurung B, et al. Prevalence of and associated risk factors for pterygium in the high altitude communities of Upper Mustang, Nepal. Nepal J Ophthalmol 2014;6:65–70.
26. Wang G-Q, Bai Z-X, Shi J, et al. Prevalence and risk factors for eye diseases, blindness, and low vision in Lhasa, Tibet. Int J Ophthalmol 2013;6:237–41.
27. Guo B, Lu P, Chen X, et al. Prevalence of dry eye disease in mongolians at high altitude in china: the henan eye study. Ophthalmic Epidemiol 2010;17:234–41.
28. Anguria P, Ntuli S, Interewicz B, et al. Traditional eye medication and pterygium occurrence in Limpopo Province. South African Med J 2012;102:687.